Euro Roundup: Pharma reform could cause loss of 3 new orphan drugs a year,...

The European Commission’s plan to reform pharmaceutical legislation could cause three fewer rare disease drugs to come to market each year, according to a...

Europe – Votre avis sur l’extension de la période de transition des RDM et...

La Commission européenne va soumettre au Parlement européen et au Conseil une proposition d'amendement modifiant les règlements (UE) 2017/745 (RDM) et (UE) 2017/746 (RDMDIV) en ce...

Europe – The designation of notified bodies under the upcoming Artificial Intelligence Act

Artificial Intelligence (AI) algorithms, in its various forms, machine learning, deep learning, etc., implemented as embedded software (SW) or standalone SW, are gaining in...
Advice for Management of Clinical trials in relation to Coronavirus

UK – Exceptional use of non-UKCA marked medical devices

A manufacturer can apply to supply a medical device that does not comply with the law to protect a patient’s health if there is...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical devices: UK approved bodies

UK approved bodies listed under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002)...

Europe – MedTech Europe’s vision for a resilient medical technology ecosystem

The digital ecosystem has dramatically changed the way in which healthcare is delivered to patients. Nowadays, medical technology companies concentrate not only on ensuring...

Europe – MDCG 2022-19 Performance study application/notification documents under Regulation (EU) 2017/746

The sponsor of a performance study is required to submit an application/notification1 to the Member State(s) in which a performance study is to be...

Europe – La prolongation de la période de transition pour les dispositifs médicaux et...

L’amendement qui modifie les Règlements (UE) 2017/745 et (UE) 2017/746 en ce qui concerne les dispositions transitoires relatives à certains dispositifs médicaux (DM) et...

Europe – MDCG 2023-3 – Questions and Answers on vigilance terms and concepts as...

This document aims to clarify important terms and concepts that are outlined in Section 2 of Chapter VII of the Regulation (EU) 2017/745 on...

Europe – The European Medical Technology in Figures 2023

Capturing the activity of the medical technology industry is vital for healthcare stakeholders, business leaders and policymakers. Updated regularly, this platform draws on data from...

NOS PROCHAINES FORMATIONS